| Literature DB >> 35859913 |
Lencho Megersa Marami1, Gemechu Berhanu2, Muluken Tekle3, Getahun Ejeta Agga4, Tariku Jibat Beyene5, Takele Beyene Tufa3, Ashenafi Feyisa Beyi6, Bedaso Mammo Edao3.
Abstract
Purpose: Staphylococcus species come from a variety of sources and can contaminate milk during milking, cause mastitis and other diseases in animals and humans. The enterotoxins they produce cause food poisoning. Our objectives were to isolate, biochemically characterize, and determine antimicrobial susceptibility profiles of Staphylococcus species from dairy farms in central Oromia, Ethiopia.Entities:
Keywords: Staphylococcus species; antimicrobial susceptibility profile; cattle; dairy farms; smallholders
Year: 2022 PMID: 35859913 PMCID: PMC9291660 DOI: 10.2147/IDR.S370592
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.177
Prevalence of Staphylococcus Species Isolates from Smallholders and Dairy Cows in Central Ethiopia
| Sample Type | Positive/Total Sample (%) | CNS n (%) | |||
|---|---|---|---|---|---|
| Raw milk | 101/135 (74.8) | 54 (40) | 17 (12.6) | 8 (5.9) | 22 (16.2) |
| Udder swab | 98/135 (72.6) | 59 (43.7) | 21 (15.5) | 9 (6.6) | 9 (6.6) |
| Utensil swab | 30/44 (68.2) | 16 (36.6) | 4 (9) | 4 (9) | 6 (13.6) |
| Milker’s hand swab | 18/25 (72) | 10 (40) | 5 (20) | 0 | 3 (12) |
| Total | 247/339 (72.9) | 139 (41) | 47 (13) | 21 (6.2) | 40 (11.7) |
Abbreviation: CNS, coagulase-negative Staphylococcus species.
Univariate Analysis of the Risk Factors for Isolation of Staphylococcus Species from Raw Milk of Cows in the Study Area
| Risk Factors | Total Sample | Positive N (%) | Regression Coefficient | P-value | |
|---|---|---|---|---|---|
| Site | Ambo Kebele 01 | 29 | 21 (72.4) | ||
| Ambo Kebele 02 | 40 | 33 (82.5) | 0.5855 | 0.319 | |
| Ambo Kebele 03 | 29 | 20 (69.0) | −0.16657 | 0.773 | |
| Guder | 37 | 27 (73.0) | 0.02817 | 0.960 | |
| Town | Ambo | 98 | 74 (75.5) | −0.02537 | 0.764 |
| Guder | 37 | 27 (73.0) | |||
| Breed | Local | 46 | 38 (82.6) | −0.6731 | 0.138 |
| Cross | 89 | 63 (70.8) | |||
| Farm type | Smallholders | 11 | 9 (81.8) | −0.4480 | 0.579 |
| Dairy farms | 124 | 92 (74.2) | |||
| Age (Years) | <3 | 71 | 53 (74.6) | 0.01869 | 0.962 |
| 3–6 | 64 | 48 (75.0) | |||
| Parity | 1–2 | 86 | 63 (73.3) | 0.2321 | 0.581 |
| ≥3 | 49 | 38 (77.6) | |||
| Lactation Stage (months) | <3 | 42 | 35 (83.3) | −0.4021 | 0.140 |
| 3–6 | 61 | 44 (72.1) | |||
| >6 | 32 | 22 (68.8) | |||
| Blind Teat | No | 115 | 88 (76.5) | −0.5625 | 0.277 |
| Yes | 20 | 13 (65.0) | |||
| Teat Lesion | No | 118 | 91 (77.1) | −0.8583 | 0.111 |
| Yes | 17 | 10 (58.8) | |||
| Tick Infestation | No | 71 | 53 (74.6) | 0.01869 | 0.962 |
| Yes | 64 | 48 (75.0) | |||
| Floor Type | Muddy | 41 | 31 (75.6) | −0.06096 | 0.888 |
| Concrete | 94 | 70 (74.5) | |||
| Usage of Towels | No | 83 | 63 (75.9) | −0.1489 | 0.713 |
| Yes | 52 | 38 (73.1) | |||
Percentage of Antimicrobial Susceptibility Profiles of S. aureus (n=20), S. intermedius (n=10), and S. hyicus (n=20)
| Antimicrobials Class | Antimicrobial Disks (Concentration) | % (No. of. Susceptible) | % (No. of. Intermediate) | % (No. of. Resistance) | |
|---|---|---|---|---|---|
| Aminoglycosides | Streptomycin (10 µg) | 100 (20) | 0 (0) | 0 (0) | |
| 70 (7) | 30 (0) | 0 (0) | |||
| 85 (17) | 0 (0) | 15 (3) | |||
| Nitrofuran | Nitrofurantoin (300µg) | 65 (13) | 35 (7) | 0 (0) | |
| 70 (7) | 30 (3) | 0 (0) | |||
| 80 (16) | 10 (2) | 10 (2) | |||
| Macrolide | Erythromycin (15μg) | 80 (16) | 20 (4) | 0 (0) | |
| 70 (7) | 30 (3) | 0 (0) | |||
| 75 (15) | 25 (5) | 0 (0) | |||
| Tetracycline | Tetracycline (30μg) | 60 (12) | 0 (0) | 40 (8) | |
| 100 (10) | 0 (0) | 0 (0) | |||
| 85 (17) | 0 (0) | 15 (3) | |||
| Doxycycline (30 μg) | 65 (13) | 15 (3) | 20 (4) | ||
| 80 (8) | 20 (2) | 0 (0) | |||
| 100 (20) | 0 (0) | 0 (0) | |||
| Fluoroquinolones | Ciprofloxacin (5 μg) | 100 (20) | 0 (0) | 0 (0) | |
| 100 (10) | 0 (0) | 0 (0) | |||
| 100 (20) | 0 (0) | 0 (0) | |||
| Sulfonamide | Sulfamethoxazole–trimethoprim (23.75μg) | 100 (20) | 0 (0) | 0 (0) | |
| 100 (10) | 0 (0) | 0 (0) | |||
| 90 (18) | 10 (2) | 0 (0) | |||
| Quinolones | Nalidixic acid (30μg) | 35 (7) | 20 (4) | 45 (9) | |
| 30 (3) | 0 (0) | 70 (7) | |||
| 30 (6) | 65 (13) | 5 (1) | |||
| Glycopeptide | Vancomycin (30 μg) | 100 (20) | 0 (0) | 0 (0) | |
| 10 (1) | 40 (4) | 50 (5) | |||
| 85 (17) | 15 (3) | 0 (0) | |||
| β-lactams | Ampicillin (10μg) | 0 (0) | 0 (0) | 100 (20) | |
| 0 (0) | 0 (0) | 100 (10) | |||
| 10 (2) | 0 (0) | 90 (18) | |||
| Amoxycillin (25μg) | 0 (0) | 10 (2) | 90 (18) | ||
| 90 (9) | 0 (0) | 10 (1) | |||
| 25 (5) | 15 (3) | 60 (12) | |||
| Penicillin G (10 unit) | 0 (0) | 0 (0) | 100 (20) | ||
| 30 (3) | 0 (0) | 70 (7) | |||
| 15 (3) | 0 (0) | 85 (17) |
Abbreviation: n, the number of isolates.
Antimicrobial Resistance Patterns of S. aureus (n=20), S. intermedius (n=10), and S. hyicus (n=20)
| Antimicrobial Resistance Pattern of | No. of Resistant Isolates | Percentage |
|---|---|---|
| NAL-AMP-PEN | 1 | 5 |
| AMP-PEN-AMX | 7 | 35 |
| NAL-AMP-PEN-AMX | 3 | 15 |
| DOX-AMP-PEN-AMX | 1 | 5 |
| TTC-AMP-PEN-AMX | 3 | 15 |
| TTC-NAL-AMP-PEN-AMX | 2 | 10 |
| TTC-DOX-NAL-AMP-PEN-AMX | 2 | 10 |
| Antimicrobial Resistance Pattern of | ||
| NAL-AMP | 1 | 10 |
| VAN-NAL-AMP | 1 | 10 |
| VAN-AMP-PCN | 2 | 20 |
| NAL-AMP-PCN | 2 | 20 |
| NAL-AMP-AMX-PCN | 1 | 10 |
| VAN-NAL-AMP-PCN | 2 | 20 |
| Antimicrobial Resistance Pattern of | ||
| NIT-STM | 1 | 5 |
| AMP-PCN | 4 | 20 |
| AMP-AMX-PCN | 8 | 40 |
| NIT-AMP-AMX-PCN | 2 | 10 |
| TTC-AMP-AMX-PCN | 1 | 5 |
| TTC-STM-AMP-PCN | 1 | 5 |
| TTC-STM-AMP-AMX-PCN | 1 | 5 |
Abbreviations: AMP, ampicillin; AMX, amoxycillin; DOX, doxycycline; NAL, nalidixic acid; NIT, nitrofurantoin; STP, streptomycin; PCN, penicillin G; TET, tetracycline; VAN, vancomycin.
Multidrug Resistance of Staphylococcus Species Isolates
| Types of Samples | Multidrug-Resistant Isolates | No. of Isolates | Class of Antimicrobial |
|---|---|---|---|
| Raw milk | 2 | Tetracycline, quinolones, and β-lactams | |
| Utensil swab | 2 | Tetracycline, quinolones, and β-lactams | |
| Milker’s hand swab | 1 | Tetracycline, quinolones, and β-lactams | |
| Raw milk | 1 | Glycopeptide, quinolones, and β-lactams | |
| Utensil swab | 2 | Glycopeptide, quinolones, and β-lactams | |
| Raw milk | 2 | Tetracycline, aminoglycosides, and β-lactams |